Antibody cocktail means happy days for treating mild Covid
AstraZeneca drug halves the risk of developing severe illness or death, tests reveal
11 October 2021 - 19:33
AstraZeneca’s antibody cocktail was effective at preventing people with mild or moderate Covid-19 infection from worsening in a study that bolsters the drugmaker’s ambitions for the product...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.